Gabapentin Market in Malaysia - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
This report contains market size and forecasts of Gabapentin in Malaysia, including the following market information:
Malaysia Gabapentin Market Revenue, 2015-2020, 2021-2026, ($ millions)
Malaysia Gabapentin Market Consumption, 2015-2020, 2021-2026, (K MT)
Malaysia Gabapentin Production Capacity, 2015-2020, 2021-2026, (K MT)
Top Five Competitors in Malaysia Gabapentin Market 2019 (%)
The global Gabapentin market was valued at 1529.6 million in 2019 and is projected to reach US$ 1637.8 million by 2026, at a CAGR of 1.7% during the forecast period. While the Gabapentin market size in Malaysia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gabapentin manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Gabapentin production and consumption in Malaysia
Total Market by Segment:
Malaysia Gabapentin Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K MT)
Malaysia Gabapentin Market Segment Percentages, By Type, 2019 (%)
Malaysia Gabapentin Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Gabapentin Market Competitors Revenues in Malaysia, by Players 2015-2020 (Estimated), ($ millions)
Total Gabapentin Market Competitors Revenues Share in Malaysia, by Players 2019 (%)
Total Malaysia Gabapentin Market Competitors Sales, by Players 2015-2020 (Estimated), (K MT)
Total Malaysia Gabapentin Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Gabapentin in Malaysia, including the following market information:
Malaysia Gabapentin Market Revenue, 2015-2020, 2021-2026, ($ millions)
Malaysia Gabapentin Market Consumption, 2015-2020, 2021-2026, (K MT)
Malaysia Gabapentin Production Capacity, 2015-2020, 2021-2026, (K MT)
Top Five Competitors in Malaysia Gabapentin Market 2019 (%)
The global Gabapentin market was valued at 1529.6 million in 2019 and is projected to reach US$ 1637.8 million by 2026, at a CAGR of 1.7% during the forecast period. While the Gabapentin market size in Malaysia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gabapentin manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Gabapentin production and consumption in Malaysia
Total Market by Segment:
Malaysia Gabapentin Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K MT)
Malaysia Gabapentin Market Segment Percentages, By Type, 2019 (%)
- Capsule
- Tablet
Malaysia Gabapentin Market Segment Percentages, By Application, 2019 (%)
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
- Others
The report also provides analysis of leading market participants including:
Total Gabapentin Market Competitors Revenues in Malaysia, by Players 2015-2020 (Estimated), ($ millions)
Total Gabapentin Market Competitors Revenues Share in Malaysia, by Players 2019 (%)
Total Malaysia Gabapentin Market Competitors Sales, by Players 2015-2020 (Estimated), (K MT)
Total Malaysia Gabapentin Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Pfizer
- Assertio Therapeutics
- TEVA
- Mylan
- Arbor Pharma
- Novartis
- Apotex
- Sun Pharmaceutical
- Aurobindo Pharma
- Intas
- Amneal
- Marksans Pharma
- Glenmark
- Alkem
- Jiangsu Enhua
- Jiangsu Hengrui
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Gabapentin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Malaysia Gabapentin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: MALAYSIA GABAPENTIN OVERALL MARKET SIZE
2.1 Malaysia Gabapentin Market Size: 2020 VS 2026
2.2 Malaysia Gabapentin Revenue, Prospects & Forecasts: 2015-2026
2.3 Malaysia Gabapentin Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Gabapentin Players in Malaysia (including Foreign and Local Companies)
3.2 Top Malaysia Gabapentin Companies Ranked by Revenue
3.3 Malaysia Gabapentin Revenue by Companies (including Foreign and Local Companies)
3.4 Malaysia Gabapentin Sales by Companies (including Foreign and Local Companies)
3.5 Malaysia Gabapentin Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Gabapentin Companies in Malaysia, by Revenue in 2019
3.7 Malaysia Manufacturers Gabapentin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gabapentin Players in Malaysia
3.8.1 List of Malaysia Tier 1 Gabapentin Companies
3.8.2 List of Malaysia Tier 2 and Tier 3 Gabapentin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Malaysia Gabapentin Market Size Markets, 2020 & 2026
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - Malaysia Gabapentin Revenue & Forecasts
4.2.1 By Type - Malaysia Gabapentin Revenue, 2015-2020
4.2.2 By Type - Malaysia Gabapentin Revenue, 2021-2026
4.2.3 By Type - Malaysia Gabapentin Revenue Market Share, 2015-2026
4.3 By Type - Malaysia Gabapentin Sales & Forecasts
4.3.1 By Type - Malaysia Gabapentin Sales, 2015-2020
4.3.2 By Type - Malaysia Gabapentin Sales, 2021-2026
4.3.3 By Type - Malaysia Gabapentin Sales Market Share, 2015-2026
4.4 By Type - Malaysia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Malaysia Gabapentin Market Size, 2020 & 2026
5.1.2 Epilepsy
5.1.3 Neuropathic Pain
5.1.4 Restless Legs Syndrome
5.1.5 Others
5.2 By Application - Malaysia Gabapentin Revenue & Forecasts
5.2.1 By Application - Malaysia Gabapentin Revenue, 2015-2020
5.2.2 By Application - Malaysia Gabapentin Revenue, 2021-2026
5.2.3 By Application - Malaysia Gabapentin Revenue Market Share, 2015-2026
5.3 By Application - Malaysia Gabapentin Sales & Forecasts
5.3.1 By Application - Malaysia Gabapentin Sales, 2015-2020
5.3.2 By Application - Malaysia Gabapentin Sales, 2021-2026
5.3.3 By Application - Malaysia Gabapentin Sales Market Share, 2015-2026
5.4 By Application - Malaysia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Pfizer
6.1.1 Pfizer Corporate Summary
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Gabapentin Major Product Offerings
6.1.4 Pfizer Sales and Revenue in Malaysia (2015-2020)
6.1.5 Pfizer Key News
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporate Summary
6.2.2 Assertio Therapeutics Business Overview
6.2.3 Assertio Therapeutics Gabapentin Major Product Offerings
6.2.4 Assertio Therapeutics Sales and Revenue in Malaysia (2015-2020)
6.2.5 Assertio Therapeutics Key News
6.3 TEVA
6.3.1 TEVA Corporate Summary
6.3.2 TEVA Business Overview
6.3.3 TEVA Gabapentin Major Product Offerings
6.3.4 TEVA Sales and Revenue in Malaysia (2015-2020)
6.3.5 TEVA Key News
6.4 Mylan
6.4.1 Mylan Corporate Summary
6.4.2 Mylan Business Overview
6.4.3 Mylan Gabapentin Major Product Offerings
6.4.4 Mylan Sales and Revenue in Malaysia (2015-2020)
6.4.5 Mylan Key News
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporate Summary
6.5.2 Arbor Pharma Business Overview
6.5.3 Arbor Pharma Gabapentin Major Product Offerings
6.5.4 Arbor Pharma Sales and Revenue in Malaysia (2015-2020)
6.5.5 Arbor Pharma Key News
6.6 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Gabapentin Major Product Offerings
6.6.4 Novartis Sales and Revenue in Malaysia (2015-2020)
6.6.5 Novartis Key News
6.7 Apotex
6.6.1 Apotex Corporate Summary
6.6.2 Apotex Business Overview
6.6.3 Apotex Gabapentin Major Product Offerings
6.4.4 Apotex Sales and Revenue in Malaysia (2015-2020)
6.7.5 Apotex Key News
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporate Summary
6.8.2 Sun Pharmaceutical Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Major Product Offerings
6.8.4 Sun Pharmaceutical Sales and Revenue in Malaysia (2015-2020)
6.8.5 Sun Pharmaceutical Key News
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporate Summary
6.9.2 Aurobindo Pharma Business Overview
6.9.3 Aurobindo Pharma Gabapentin Major Product Offerings
6.9.4 Aurobindo Pharma Sales and Revenue in Malaysia (2015-2020)
6.9.5 Aurobindo Pharma Key News
6.10 Intas
6.10.1 Intas Corporate Summary
6.10.2 Intas Business Overview
6.10.3 Intas Gabapentin Major Product Offerings
6.10.4 Intas Sales and Revenue in Malaysia (2015-2020)
6.10.5 Intas Key News
6.11 Amneal
6.11.1 Amneal Corporate Summary
6.11.2 Amneal Gabapentin Business Overview
6.11.3 Amneal Gabapentin Major Product Offerings
6.11.4 Amneal Sales and Revenue in Malaysia (2015-2020)
6.11.5 Amneal Key News
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporate Summary
6.12.2 Marksans Pharma Gabapentin Business Overview
6.12.3 Marksans Pharma Gabapentin Major Product Offerings
6.12.4 Marksans Pharma Sales and Revenue in Malaysia (2015-2020)
6.12.5 Marksans Pharma Key News
6.13 Glenmark
6.13.1 Glenmark Corporate Summary
6.13.2 Glenmark Gabapentin Business Overview
6.13.3 Glenmark Gabapentin Major Product Offerings
6.13.4 Glenmark Sales and Revenue in Malaysia (2015-2020)
6.13.5 Glenmark Key News
6.14 Alkem
6.14.1 Alkem Corporate Summary
6.14.2 Alkem Gabapentin Business Overview
6.14.3 Alkem Gabapentin Major Product Offerings
6.14.4 Alkem Sales and Revenue in Malaysia (2015-2020)
6.14.5 Alkem Key News
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporate Summary
6.15.2 Jiangsu Enhua Gabapentin Business Overview
6.15.3 Jiangsu Enhua Gabapentin Major Product Offerings
6.15.4 Jiangsu Enhua Sales and Revenue in Malaysia (2015-2020)
6.15.5 Jiangsu Enhua Key News
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporate Summary
6.16.2 Jiangsu Hengrui Gabapentin Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Major Product Offerings
6.16.4 Jiangsu Hengrui Sales and Revenue in Malaysia (2015-2020)
6.16.5 Jiangsu Hengrui Key News
6.17 Sailike
6.17.1 Sailike Corporate Summary
6.17.2 Sailike Gabapentin Business Overview
6.17.3 Sailike Gabapentin Major Product Offerings
6.17.4 Sailike Sales and Revenue in Malaysia (2015-2020)
6.17.5 Sailike Key News
7 GABAPENTIN PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Gabapentin Production Capacity and Value in Malaysia, Situation Analysis and Prediction, 2015-2026
7.1.1 Malaysia Gabapentin Production Capacity, 2015-2026
7.1.2 Malaysia Gabapentin Production 2015-2026
7.1.3 Malaysia Gabapentin Production Value 2015-2026
7.2 Key Local Gabapentin Manufacturers in Malaysia
7.2.1 Malaysia Key Local Gabapentin Manufacturers Production Capacity
7.2.2 Malaysia Key Local Gabapentin Manufacturers Production
7.2.3 Malaysia Key Local Gabapentin Manufacturers Production Value
7.2.4 The Proportion of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
7.3 Gabapentin Export and Import in Malaysia
7.3.1 Malaysia Gabapentin Export Market
7.3.2 Malaysia Gabapentin Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Malaysia Gabapentin Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON GABAPENTIN SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Gabapentin Distributors and Sales Agents in Malaysia
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Gabapentin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Malaysia Gabapentin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: MALAYSIA GABAPENTIN OVERALL MARKET SIZE
2.1 Malaysia Gabapentin Market Size: 2020 VS 2026
2.2 Malaysia Gabapentin Revenue, Prospects & Forecasts: 2015-2026
2.3 Malaysia Gabapentin Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Gabapentin Players in Malaysia (including Foreign and Local Companies)
3.2 Top Malaysia Gabapentin Companies Ranked by Revenue
3.3 Malaysia Gabapentin Revenue by Companies (including Foreign and Local Companies)
3.4 Malaysia Gabapentin Sales by Companies (including Foreign and Local Companies)
3.5 Malaysia Gabapentin Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Gabapentin Companies in Malaysia, by Revenue in 2019
3.7 Malaysia Manufacturers Gabapentin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gabapentin Players in Malaysia
3.8.1 List of Malaysia Tier 1 Gabapentin Companies
3.8.2 List of Malaysia Tier 2 and Tier 3 Gabapentin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Malaysia Gabapentin Market Size Markets, 2020 & 2026
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - Malaysia Gabapentin Revenue & Forecasts
4.2.1 By Type - Malaysia Gabapentin Revenue, 2015-2020
4.2.2 By Type - Malaysia Gabapentin Revenue, 2021-2026
4.2.3 By Type - Malaysia Gabapentin Revenue Market Share, 2015-2026
4.3 By Type - Malaysia Gabapentin Sales & Forecasts
4.3.1 By Type - Malaysia Gabapentin Sales, 2015-2020
4.3.2 By Type - Malaysia Gabapentin Sales, 2021-2026
4.3.3 By Type - Malaysia Gabapentin Sales Market Share, 2015-2026
4.4 By Type - Malaysia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Malaysia Gabapentin Market Size, 2020 & 2026
5.1.2 Epilepsy
5.1.3 Neuropathic Pain
5.1.4 Restless Legs Syndrome
5.1.5 Others
5.2 By Application - Malaysia Gabapentin Revenue & Forecasts
5.2.1 By Application - Malaysia Gabapentin Revenue, 2015-2020
5.2.2 By Application - Malaysia Gabapentin Revenue, 2021-2026
5.2.3 By Application - Malaysia Gabapentin Revenue Market Share, 2015-2026
5.3 By Application - Malaysia Gabapentin Sales & Forecasts
5.3.1 By Application - Malaysia Gabapentin Sales, 2015-2020
5.3.2 By Application - Malaysia Gabapentin Sales, 2021-2026
5.3.3 By Application - Malaysia Gabapentin Sales Market Share, 2015-2026
5.4 By Application - Malaysia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Pfizer
6.1.1 Pfizer Corporate Summary
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Gabapentin Major Product Offerings
6.1.4 Pfizer Sales and Revenue in Malaysia (2015-2020)
6.1.5 Pfizer Key News
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporate Summary
6.2.2 Assertio Therapeutics Business Overview
6.2.3 Assertio Therapeutics Gabapentin Major Product Offerings
6.2.4 Assertio Therapeutics Sales and Revenue in Malaysia (2015-2020)
6.2.5 Assertio Therapeutics Key News
6.3 TEVA
6.3.1 TEVA Corporate Summary
6.3.2 TEVA Business Overview
6.3.3 TEVA Gabapentin Major Product Offerings
6.3.4 TEVA Sales and Revenue in Malaysia (2015-2020)
6.3.5 TEVA Key News
6.4 Mylan
6.4.1 Mylan Corporate Summary
6.4.2 Mylan Business Overview
6.4.3 Mylan Gabapentin Major Product Offerings
6.4.4 Mylan Sales and Revenue in Malaysia (2015-2020)
6.4.5 Mylan Key News
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporate Summary
6.5.2 Arbor Pharma Business Overview
6.5.3 Arbor Pharma Gabapentin Major Product Offerings
6.5.4 Arbor Pharma Sales and Revenue in Malaysia (2015-2020)
6.5.5 Arbor Pharma Key News
6.6 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Gabapentin Major Product Offerings
6.6.4 Novartis Sales and Revenue in Malaysia (2015-2020)
6.6.5 Novartis Key News
6.7 Apotex
6.6.1 Apotex Corporate Summary
6.6.2 Apotex Business Overview
6.6.3 Apotex Gabapentin Major Product Offerings
6.4.4 Apotex Sales and Revenue in Malaysia (2015-2020)
6.7.5 Apotex Key News
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporate Summary
6.8.2 Sun Pharmaceutical Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Major Product Offerings
6.8.4 Sun Pharmaceutical Sales and Revenue in Malaysia (2015-2020)
6.8.5 Sun Pharmaceutical Key News
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporate Summary
6.9.2 Aurobindo Pharma Business Overview
6.9.3 Aurobindo Pharma Gabapentin Major Product Offerings
6.9.4 Aurobindo Pharma Sales and Revenue in Malaysia (2015-2020)
6.9.5 Aurobindo Pharma Key News
6.10 Intas
6.10.1 Intas Corporate Summary
6.10.2 Intas Business Overview
6.10.3 Intas Gabapentin Major Product Offerings
6.10.4 Intas Sales and Revenue in Malaysia (2015-2020)
6.10.5 Intas Key News
6.11 Amneal
6.11.1 Amneal Corporate Summary
6.11.2 Amneal Gabapentin Business Overview
6.11.3 Amneal Gabapentin Major Product Offerings
6.11.4 Amneal Sales and Revenue in Malaysia (2015-2020)
6.11.5 Amneal Key News
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporate Summary
6.12.2 Marksans Pharma Gabapentin Business Overview
6.12.3 Marksans Pharma Gabapentin Major Product Offerings
6.12.4 Marksans Pharma Sales and Revenue in Malaysia (2015-2020)
6.12.5 Marksans Pharma Key News
6.13 Glenmark
6.13.1 Glenmark Corporate Summary
6.13.2 Glenmark Gabapentin Business Overview
6.13.3 Glenmark Gabapentin Major Product Offerings
6.13.4 Glenmark Sales and Revenue in Malaysia (2015-2020)
6.13.5 Glenmark Key News
6.14 Alkem
6.14.1 Alkem Corporate Summary
6.14.2 Alkem Gabapentin Business Overview
6.14.3 Alkem Gabapentin Major Product Offerings
6.14.4 Alkem Sales and Revenue in Malaysia (2015-2020)
6.14.5 Alkem Key News
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporate Summary
6.15.2 Jiangsu Enhua Gabapentin Business Overview
6.15.3 Jiangsu Enhua Gabapentin Major Product Offerings
6.15.4 Jiangsu Enhua Sales and Revenue in Malaysia (2015-2020)
6.15.5 Jiangsu Enhua Key News
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporate Summary
6.16.2 Jiangsu Hengrui Gabapentin Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Major Product Offerings
6.16.4 Jiangsu Hengrui Sales and Revenue in Malaysia (2015-2020)
6.16.5 Jiangsu Hengrui Key News
6.17 Sailike
6.17.1 Sailike Corporate Summary
6.17.2 Sailike Gabapentin Business Overview
6.17.3 Sailike Gabapentin Major Product Offerings
6.17.4 Sailike Sales and Revenue in Malaysia (2015-2020)
6.17.5 Sailike Key News
7 GABAPENTIN PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Gabapentin Production Capacity and Value in Malaysia, Situation Analysis and Prediction, 2015-2026
7.1.1 Malaysia Gabapentin Production Capacity, 2015-2026
7.1.2 Malaysia Gabapentin Production 2015-2026
7.1.3 Malaysia Gabapentin Production Value 2015-2026
7.2 Key Local Gabapentin Manufacturers in Malaysia
7.2.1 Malaysia Key Local Gabapentin Manufacturers Production Capacity
7.2.2 Malaysia Key Local Gabapentin Manufacturers Production
7.2.3 Malaysia Key Local Gabapentin Manufacturers Production Value
7.2.4 The Proportion of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
7.3 Gabapentin Export and Import in Malaysia
7.3.1 Malaysia Gabapentin Export Market
7.3.2 Malaysia Gabapentin Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Malaysia Gabapentin Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON GABAPENTIN SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Gabapentin Distributors and Sales Agents in Malaysia
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Gabapentin in Malaysia
Table 2. Top Players in Malaysia, Ranking by Revenue (2019)
Table 3. Malaysia Gabapentin Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Malaysia Gabapentin Revenue Share by Companies, 2015-2020
Table 5. Malaysia Gabapentin Sales by Companies, (K MT), 2015-2020
Table 6. Malaysia Gabapentin Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Gabapentin Price (2015-2020) (USD/MT)
Table 8. Malaysia Manufacturers Gabapentin Product Type
Table 9. List of Malaysia Tier 1 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Malaysia Tier 2 and Tier 3 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Gabapentin Revenue in Malaysia (US$, Mn), 2015-2020
Table 12. By Type - Gabapentin Revenue in Malaysia (US$, Mn), 2021-2026
Table 13. By Type - Gabapentin Sales in Malaysia (K MT), 2015-2020
Table 14. By Type - Gabapentin Sales in Malaysia (K MT), 2021-2026
Table 15. By Application - Gabapentin Revenue in Malaysia, (US$, Mn), 2015-2020
Table 16. By Application - Gabapentin Revenue in Malaysia, (US$, Mn), 2021-2026
Table 17. By Application - Gabapentin Sales in Malaysia, (K MT), 2015-2020
Table 18. By Application - Gabapentin Sales in Malaysia, (K MT), 2021-2026
Table 19. Pfizer Corporate Summary
Table 20. Pfizer Gabapentin Product Offerings
Table 21. Pfizer Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Assertio Therapeutics Corporate Summary
Table 23. Assertio Therapeutics Gabapentin Product Offerings
Table 24. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. TEVA Corporate Summary
Table 26. TEVA Gabapentin Product Offerings
Table 27. TEVA Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Mylan Corporate Summary
Table 29. Mylan Gabapentin Product Offerings
Table 30. Mylan Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. Arbor Pharma Corporate Summary
Table 32. Arbor Pharma Gabapentin Product Offerings
Table 33. Arbor Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Gabapentin Product Offerings
Table 36. Novartis Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Apotex Corporate Summary
Table 38. Apotex Gabapentin Product Offerings
Table 39. Apotex Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. Sun Pharmaceutical Corporate Summary
Table 41. Sun Pharmaceutical Gabapentin Product Offerings
Table 42. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. Aurobindo Pharma Corporate Summary
Table 44. Aurobindo Pharma Gabapentin Product Offerings
Table 45. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. Intas Corporate Summary
Table 47. Intas Gabapentin Product Offerings
Table 48. Intas Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. Amneal Corporate Summary
Table 50. Amneal Gabapentin Product Offerings
Table 51. Amneal Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. Marksans Pharma Corporate Summary
Table 53. Marksans Pharma Gabapentin Product Offerings
Table 54. Marksans Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. Glenmark Corporate Summary
Table 56. Glenmark Gabapentin Product Offerings
Table 57. Glenmark Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Alkem Corporate Summary
Table 59. Alkem Gabapentin Product Offerings
Table 60. Alkem Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Jiangsu Enhua Corporate Summary
Table 62. Jiangsu Enhua Gabapentin Product Offerings
Table 63. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. Jiangsu Hengrui Corporate Summary
Table 65. Jiangsu Hengrui Gabapentin Product Offerings
Table 66. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 67. Sailike Corporate Summary
Table 68. Sailike Gabapentin Product Offerings
Table 69. Sailike Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 70. Gabapentin Production Capacity (K MT) of Local Manufacturers in Malaysia, 2015-2020
Table 71. Gabapentin Production (K MT) of Local Manufacturers in Malaysia, 2015-2020
Table 72. Malaysia Gabapentin Production Market Share of Local Manufacturers, 2015-2020
Table 73. Gabapentin Production Value (US$, Mn) of Local Manufacturers in Malaysia, 2015-2020
Table 74. Malaysia Gabapentin Production Value Market Share of Local Manufacturers, 2015-2020
Table 75. The Percentage of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 76. The Percentage of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 77. Dangeguojia Gabapentin Sales (Consumption), Production, Export and Import, 2015-2020
Table 78. Raw Materials and Suppliers
Table 79. Gabapentin Downstream Clients in Malaysia
Table 80. Gabapentin Distributors and Sales Agents in Malaysia
Table 1. Key Players of Gabapentin in Malaysia
Table 2. Top Players in Malaysia, Ranking by Revenue (2019)
Table 3. Malaysia Gabapentin Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Malaysia Gabapentin Revenue Share by Companies, 2015-2020
Table 5. Malaysia Gabapentin Sales by Companies, (K MT), 2015-2020
Table 6. Malaysia Gabapentin Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Gabapentin Price (2015-2020) (USD/MT)
Table 8. Malaysia Manufacturers Gabapentin Product Type
Table 9. List of Malaysia Tier 1 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Malaysia Tier 2 and Tier 3 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Gabapentin Revenue in Malaysia (US$, Mn), 2015-2020
Table 12. By Type - Gabapentin Revenue in Malaysia (US$, Mn), 2021-2026
Table 13. By Type - Gabapentin Sales in Malaysia (K MT), 2015-2020
Table 14. By Type - Gabapentin Sales in Malaysia (K MT), 2021-2026
Table 15. By Application - Gabapentin Revenue in Malaysia, (US$, Mn), 2015-2020
Table 16. By Application - Gabapentin Revenue in Malaysia, (US$, Mn), 2021-2026
Table 17. By Application - Gabapentin Sales in Malaysia, (K MT), 2015-2020
Table 18. By Application - Gabapentin Sales in Malaysia, (K MT), 2021-2026
Table 19. Pfizer Corporate Summary
Table 20. Pfizer Gabapentin Product Offerings
Table 21. Pfizer Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Assertio Therapeutics Corporate Summary
Table 23. Assertio Therapeutics Gabapentin Product Offerings
Table 24. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. TEVA Corporate Summary
Table 26. TEVA Gabapentin Product Offerings
Table 27. TEVA Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Mylan Corporate Summary
Table 29. Mylan Gabapentin Product Offerings
Table 30. Mylan Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. Arbor Pharma Corporate Summary
Table 32. Arbor Pharma Gabapentin Product Offerings
Table 33. Arbor Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Gabapentin Product Offerings
Table 36. Novartis Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Apotex Corporate Summary
Table 38. Apotex Gabapentin Product Offerings
Table 39. Apotex Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. Sun Pharmaceutical Corporate Summary
Table 41. Sun Pharmaceutical Gabapentin Product Offerings
Table 42. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. Aurobindo Pharma Corporate Summary
Table 44. Aurobindo Pharma Gabapentin Product Offerings
Table 45. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. Intas Corporate Summary
Table 47. Intas Gabapentin Product Offerings
Table 48. Intas Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. Amneal Corporate Summary
Table 50. Amneal Gabapentin Product Offerings
Table 51. Amneal Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. Marksans Pharma Corporate Summary
Table 53. Marksans Pharma Gabapentin Product Offerings
Table 54. Marksans Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. Glenmark Corporate Summary
Table 56. Glenmark Gabapentin Product Offerings
Table 57. Glenmark Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Alkem Corporate Summary
Table 59. Alkem Gabapentin Product Offerings
Table 60. Alkem Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Jiangsu Enhua Corporate Summary
Table 62. Jiangsu Enhua Gabapentin Product Offerings
Table 63. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. Jiangsu Hengrui Corporate Summary
Table 65. Jiangsu Hengrui Gabapentin Product Offerings
Table 66. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 67. Sailike Corporate Summary
Table 68. Sailike Gabapentin Product Offerings
Table 69. Sailike Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 70. Gabapentin Production Capacity (K MT) of Local Manufacturers in Malaysia, 2015-2020
Table 71. Gabapentin Production (K MT) of Local Manufacturers in Malaysia, 2015-2020
Table 72. Malaysia Gabapentin Production Market Share of Local Manufacturers, 2015-2020
Table 73. Gabapentin Production Value (US$, Mn) of Local Manufacturers in Malaysia, 2015-2020
Table 74. Malaysia Gabapentin Production Value Market Share of Local Manufacturers, 2015-2020
Table 75. The Percentage of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 76. The Percentage of Gabapentin Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 77. Dangeguojia Gabapentin Sales (Consumption), Production, Export and Import, 2015-2020
Table 78. Raw Materials and Suppliers
Table 79. Gabapentin Downstream Clients in Malaysia
Table 80. Gabapentin Distributors and Sales Agents in Malaysia
LIST OF FIGURES
Figure 1. Gabapentin Segment by Type
Figure 2. Gabapentin Segment by Application
Figure 3. Dangeguojia Gabapentin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Gabapentin Market Size in Malaysia, (US$, Mn) & (K MT): 2020 VS 2026
Figure 6. Malaysia Gabapentin Revenue, 2015-2026 (US$, Mn)
Figure 7. Gabapentin Sales in Malaysia: 2015-2026 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Gabapentin Revenue in 2019
Figure 9. By Type - Malaysia Gabapentin Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Malaysia Gabapentin Market Share, 2015-2020
Figure 11. By Type - Malaysia Gabapentin Market Share, 2020-2026
Figure 12. By Type - Malaysia Gabapentin Price (USD/MT), 2015-2026
Figure 13. By Application - Gabapentin Revenue in Malaysia (US$, Mn), 2020 & 2026
Figure 14. By Application - Malaysia Gabapentin Market Share, 2015-2020
Figure 15. By Application - Malaysia Gabapentin Market Share, 2020-2026
Figure 16. By Application -Malaysia Gabapentin Price (USD/MT), 2015-2026
Figure 17. Malaysia Gabapentin Production Capacity (K MT), 2015-2026
Figure 18. Malaysia Gabapentin Actual Output (K MT), 2015-2026
Figure 19. Malaysia Gabapentin Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Malaysia Gabapentin Export Destination, 2019
Figure 21. The Source of Imports of Malaysia Gabapentin, 2019
Figure 22. PEST Analysis for Malaysia Gabapentin Market in 2020
Figure 23. Gabapentin Market Opportunities & Trends in Malaysia
Figure 24. Gabapentin Market Drivers in Malaysia
Figure 25. Gabapentin Market Restraints in Malaysia
Figure 26. Gabapentin Industry Value Chain
Figure 1. Gabapentin Segment by Type
Figure 2. Gabapentin Segment by Application
Figure 3. Dangeguojia Gabapentin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Gabapentin Market Size in Malaysia, (US$, Mn) & (K MT): 2020 VS 2026
Figure 6. Malaysia Gabapentin Revenue, 2015-2026 (US$, Mn)
Figure 7. Gabapentin Sales in Malaysia: 2015-2026 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Gabapentin Revenue in 2019
Figure 9. By Type - Malaysia Gabapentin Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Malaysia Gabapentin Market Share, 2015-2020
Figure 11. By Type - Malaysia Gabapentin Market Share, 2020-2026
Figure 12. By Type - Malaysia Gabapentin Price (USD/MT), 2015-2026
Figure 13. By Application - Gabapentin Revenue in Malaysia (US$, Mn), 2020 & 2026
Figure 14. By Application - Malaysia Gabapentin Market Share, 2015-2020
Figure 15. By Application - Malaysia Gabapentin Market Share, 2020-2026
Figure 16. By Application -Malaysia Gabapentin Price (USD/MT), 2015-2026
Figure 17. Malaysia Gabapentin Production Capacity (K MT), 2015-2026
Figure 18. Malaysia Gabapentin Actual Output (K MT), 2015-2026
Figure 19. Malaysia Gabapentin Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Malaysia Gabapentin Export Destination, 2019
Figure 21. The Source of Imports of Malaysia Gabapentin, 2019
Figure 22. PEST Analysis for Malaysia Gabapentin Market in 2020
Figure 23. Gabapentin Market Opportunities & Trends in Malaysia
Figure 24. Gabapentin Market Drivers in Malaysia
Figure 25. Gabapentin Market Restraints in Malaysia
Figure 26. Gabapentin Industry Value Chain
